Journal details
INFLAMMOPHARMACOLOGY
SPRINGER BASEL AG · ISSN 0925-4692 · eISSN 1568-5608
SCIEScopusMEDLINEPubMedPMC
Overview
INFLAMMOPHARMACOLOGY is a Immunology · Toxicology journal published by SPRINGER BASEL AG (Netherlands). Use this page to check its impact factor, JCR quartile, CAS zone and indexing before you submit. Always confirm the scope, APC and policies on the journal's official website.
Publication output
2026: 197 articles · 2025: 458 articles · 2024: 220 articles. Source: OpenAlex open data.
FAQ
What is the impact factor of INFLAMMOPHARMACOLOGY?
The impact factor recorded for INFLAMMOPHARMACOLOGY is 6.3 (2025 JCR release), JCR quartile Q1.
What is the CAS zone (Chinese Academy of Sciences ranking) of INFLAMMOPHARMACOLOGY?
INFLAMMOPHARMACOLOGY is listed in CAS Zone 3.
Which databases index INFLAMMOPHARMACOLOGY?
INFLAMMOPHARMACOLOGY is indexed in SCIE, Scopus, MEDLINE, PubMed, PMC. Confirm on the journal website and the database itself before submitting.